Although the epilepsy and neurology communities have position papers on a number of topics pertaining to epilepsy diagnosis and management, no current paper exists for the rationale and appropriate indications for epilepsy monitoring unit (EMU) evaluation. General neurologists, hospital administrators, and insurers also have yet to fully understand the role this type of testing has in the diagnosis and management of individuals with paroxysmal neurologic symptoms. This review outlines the indications for long-term video-electroencephalography (VEEG) for typical elective admissions to a specialized inpatient setting. The common techniques used in EMUs to obtain diagnostic information are reviewed. The added benefit of safety measures and clinical testing above that available for routine or long-term ambulatory electroencephalography is also discussed. The indications for admission to the EMU include differential diagnosis of paroxysmal spells, characterization of seizure types, presurgical epilepsy evaluations, seizure quantification, monitoring medication adjustment in a safe setting, and differentiation between seizures and side effects. We conclude that the appropriate use of this specialized testing can lead to an early and correct diagnosis in a variety of clinical circumstances. The EMU evaluation is considered the gold standard test for the definitive diagnosis of epilepsy and seizure-like spells.
1. Determine whether spells are epileptic seizures (spell classification or differential diagnosis), 2. Identify the type of seizures occurring in individuals with known epilepsy (seizure/syndrome classification), 3. Localize the seizure focus for consideration of epilepsy surgery (presurgical evaluation), 4. Perform ictal single photon emission computed tomography (SPECT), 5. Monitor seizure frequency (seizure quantification), 6 . Adjust medications to control seizures (medication adjustment), and 7. Differentiate between seizures and medication side effects This paper is focused on elective admission to an inpatient EMU, but urgent admission is also indicated when patients are at risk of harm, especially when outpatient treatment is not successful in reducing seizures during an exacerbation of seizure frequency, when it is suspected that episodes may not be seizures, or when an outpatient evaluation cannot determine whether acute symptoms are seizures or medication side effects.
The International League Against Epilepsy defines drugresistant epilepsy as "failure of adequate trials of 2 tolerated and appropriately chosen and used [antiepileptic drug] AED schedules (whether as monotherapies or in combination) to achieve sustained seizure freedom." 4 Individuals who have either persistent seizures or side effects after trials of 2 antiepileptic drugs (AEDs) should be considered to have failed standard treatment and should be referred to a level 3 or 4 specialty epilepsy center. Level 3 and 4 epilepsy centers, as accredited by the National Association of Epilepsy Centers (NAEC), provide an interdisciplinary and comprehensive approach to the diagnosis and treatment of patients with epilepsy and other paroxysmal events. The primary goal of the epilepsy treatment team is to achieve complete seizure control or at least a meaningful reduction in the frequency of seizures and/or medical side effects in people with intractable epilepsy. There are 4 common elements of all level 3 and 4 epilepsy centers-interdisciplinary care team approach, electrodiagnostic services and facilities, safety protocols (examples of which can be found at www.naec-epilepsy.org) and quality measures, and patient education. This paper is focused on the electrodiagnostic services provided in the inpatient EMU of level 3 and 4 epilepsy centers for patients electively admitted for a comprehensive epilepsy evaluation. Other elements of epilepsy centers can be found in Labiner et al. 5 
| VEEG IN THE EMU
VEEG is a synchronized real-time continuous EEG (recording of cerebral electrical activity) and video recording of the patient in a specifically equipped room. 6 VEEG allows
Key Points
• VEEG performed in EMUs differs from outpatient ambulatory VEEG, inpatient bedside VEEG, and VEEG in the ICU
• Three common indications for EMU admissions are differential diagnosis, presurgical evaluation, and characterization of seizure types
• The inpatient EMU evaluation is essential to determine whether individuals with drug-resistant epilepsy are candidates for epilepsy surgery
• Monitoring in a specialized EMU is likely safer, more efficient, and more effective than bedside VEEG monitoring
• The appropriate use of specialized, inpatient EMU evaluation can lead to an early and correct diagnosis in many clinical circumstances precise electroclinical correlation to answer a specific referral question. 5, 7 Scalp EEG electrodes should be placed according to the International 10-20 electrode system. 8 In certain circumstances, additional electrodes (such as F9, T9, P9; F10, T10, P10) might provide a better sampling of inferior frontal and temporal lobes in patients with suspected epilepsy and presurgical patients. 9 Additional electrodes may be required for some patients. 10 In the course of epilepsy surgery evaluation, when seizures cannot be localized adequately by scalp EEG, monitoring with intracranial EEG electrodes may be necessary.
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VEEG performed in a specialized EMU is distinct from inpatient VEEG performed elsewhere in the hospital, at the patient's bedside or in an intensive care unit (ICU), for example. VEEG at the bedside can be performed at any bed in a hospital to which an EEG machine can be transported, but is suboptimal for the epilepsy evaluation as described here, because the recording may not be continuously monitored. EMU monitoring is likely safer, more efficient at capturing spells, and more effective than bedside VEEG monitoring, but requires more resources than other types of hospitalization.
As part of its epilepsy center accreditation program, the NAEC recommends that VEEG in an EMU ideally should be continuously monitored by a qualified health professional to maximize safety and recording fidelity. Continuous supervision of EEG ensures the technical integrity of the recording so that if EEG electrodes become dry or dislodged, or malfunction, they can be fixed before a spell occurs. Continuous supervision of the individual, typically through video monitoring, permits the nursing staff to be alerted when a spell occurs, which ensures that the person's safety is addressed immediately when a seizure occurs. Continuous observation ensures that the individual is properly tested during a spell to facilitate diagnosis of the spell or seizure type. Inpatient nursing staff can perform ancillary testing during events, such as obtaining drug levels and serum glucose, and monitoring heart rate and orthostatic blood pressures, which may provide important information that leads to the proper diagnosis. Specialized epilepsy nurses are trained to test and care for people during seizures and to detect and treat spells and seizures to reduce morbidity and mortality, such as by standardized physical examination during seizures, avoiding aspiration, and recognizing other complications when they occur. Equally important is the epilepsy-specific education they provide individuals in between seizures about seizure first aid, seizure safety, and the importance of adhering to medication dosing.
Individuals hospitalized for evaluation of seizures and epilepsy are at risk for falling, injuries, fractures, aspiration, and status epilepticus. 12, 13 The EMU environment is designed to reduce the risk of these problems. Accredited epilepsy centers are required to have specific safety protocols in place to prevent these problems and to provide guidance to nurses and staff for notifying the responsible physician and instituting treatment with an appropriate rescue medication when seizures are so frequent or prolonged as to expose individuals to more risk than necessary.
14 Even with continuous observation and safety protocols, deaths have occurred in EMUs from sudden unexpected death in epilepsy. 15 This highlights the importance of inpatient evaluation, particularly if medication withdrawal is planned to facilitate seizures.
One of the most common indications for EMU admission for VEEG is to determine whether paroxysmal spells are epileptic seizures (Table 1) . 16 In addition to epileptic seizures, the common diagnostic concerns include vasovagal syncope, cardiogenic syncope, nonepileptic events (also termed pseudoseizures, psychogenic seizures, or nonepileptic seizures), and paroxysmal movement disorders. 17 EMU evaluation has been demonstrated to have added value in the diagnosis of epilepsy, 18, 19 and it is cost-effective. 20, 21 EMU evaluation can be a crucial and definitive diagnostic test for individuals with paroxysmal spells of unclear etiology. Up to one-third, or more, of individuals referred for EMU evaluation are found to have nonepileptic events. 22, 23 About 10% of individuals with nonepileptic events also have epileptic seizures. 24 Management of these individuals is challenging, especially when they have frequent spells requiring urgent medical attention. It is essential to have an understanding of the characteristics of an individual's epileptic and nonepileptic events, as well as knowledge of the proportion of each event type, to provide best care and to avoid unnecessary treatment. Nonepileptic psychogenic events, often due to depression, anxiety, or other mental health problems, are treated with psychotherapy or behavioral medications by psychologists and/or psychiatrists, whereas seizures are treated by neurologists. The EMU evaluation is the best test to separate the characteristics and proportion of epileptic and nonepileptic events. 25 
| Seizure/syndrome classification
Some seizure types or seizure syndromes respond better to specific AEDs. 26, 27 EMU evaluation to record and precisely diagnose seizure type allows clinicians to select an optimal medication. Conversely, some AEDs exacerbate particular seizure types; for example, medications acting at the sodium channel-such as phenytoin, carbamazepine, and lamotrigine-can worsen seizures in Dravet syndrome, carbamazepine may worsen absence seizures, and carbamazepine or phenytoin-and rarely lamotrigine-may exacerbate myoclonic seizures. 28, 29 Clinical history and the results of routine EEG alone may not be diagnostic of a specific seizure type, and clinicians may inadvertently select a suboptimal initial medication when the specific seizure type is unknown. In other cases, an individual may actually experience an exacerbation of seizures during an AED trial. In these situations, recording seizures with VEEG in the EMU setting can clarify the diagnosis and provide guidance for selecting optimal treatment. 30 
| Presurgical evaluation
The EMU evaluation is an essential component of a presurgical evaluation to determine whether individuals with drug-resistant epilepsy are candidates for epilepsy surgery. 7 The noninvasive scalp VEEG study in the EMU (as part of what is traditionally termed phase I studies) plays a dual role, first in confirming that the individual's paroxysmal events are epileptic, and second in localizing the brain region producing the seizures. 31, 32 To obtain the greatest information about an individual's epilepsy, it is necessary not only to document interictal electrographic activity but also to record video and EEG during seizures. Increasing seizure probability during an EMU evaluation requires reduction of AEDs or other provocative measures such as sleep deprivation. The EMU environment is designed to maintain safety as clinicians take these steps to increase seizure likelihood and possibly the severity of the seizures. Ictal SPECT may be part of a presurgical evaluation, as further described in Section 3.4. In individuals where the phase I study does not conclusively localize the epileptogenic zone, an intracranial VEEG study in the EMU in which electrodes are implanted surgically on the surface or within the brain (often termed phase II study) may be indicated to definitively localize the epileptogenic zone. 33 Monitoring for seizures in a phase II study must be performed in the EMU to maintain safety in individuals with implanted electrodes. For example, seizures may dislodge intracranial electrodes or the electrode cables may create a conduit for cerebrospinal fluid (CSF) leaks or infection.
| Ictal SPECT
Ictal SPECT may be the primary reason for EMU admission, as it is performed essentially exclusively on inpatients. This test is performed by vigilant VEEG monitoring to detect the onset of a seizure so that a radiotracer can be urgently injected within 90 seconds of seizure onset; it is taken up focally in the brain in proportion to blood flow and may demonstrate a focal area of increased activity at the site of seizure onset by nuclear imaging obtained after the injection. 
| ANTICIPATED COURSE OF TREATMENT IN EMU FOR MEDICAL AND PRESURGICAL EVALUATIONS
Given its varied uses, admissions for VEEG will have different lengths of stay based on the diagnostic question posed. Classifying a frequently occurring event-either seizure or nonepileptic seizure-can often be done quickly. On the other hand, classifying a rare event or recording multiple events as required for a presurgical evaluation usually requires a longer stay. However, although the questions may differ, the admissions all strive to capture the individual's typical events utilizing various methods. The duration of an EMU admission is determined by the time needed to record a representative sample of the typical events experienced by the individual, and the clinical assessment of the seizures and spells. 41 All of a person's typical spell types must be recorded before a complete diagnosis can be made. For example, because some people with nonepileptic events also have epileptic seizures, the presence of interictal epileptiform activity on the EEG also raises the concern that there may be concomitant epileptic and nonepileptic events; this situation may warrant more prolonged monitoring to withdraw AEDs to detect whether epileptic events are also present. For presurgical evaluation, at least 3, and usually 5, seizures must be recorded to ensure that clinical and EEG features of the seizures are stereotyped and do not arise from >1 focus. 42 If the location is not clear, then many more seizures must be recorded; for patients likely to have multifocal seizures, >9 seizures may be required. 43 At least 4-7 days of recording is usually needed to capture a sufficient number of seizures, but sometimes longer recordings are necessary. The length of stay will vary based on the indication for the EMU study. Seizures are by their nature intermittent events; they occur unpredictably and at irregular intervals. Seizure frequency varies greatly both within a single person and across people. An individual may have daily seizures for a few weeks, and then he or she may have <1 per week for a prolonged period. Alternatively, a person may have only monthly seizures while on medications but then daily or more often when medications are withdrawn. Admission to an EMU is efficient when it can be anticipated that a seizure will occur during the admission. Admission may be brief when patients have daily seizures. However, most patients have seizures less frequently than this. Seizures will usually occur during routine EMU admission if they are occurring at least once per week at home or if it is anticipated they will occur upon medication withdrawal. Once admitted to an EMU, an individual is assessed daily by the treatment team to determine whether a seizure has occurred and to plan what adjustments are needed that day to increase the likelihood of a seizure occurring, such as reducing AEDs. An individual's time in the EMU must be long enough to reasonably expect to capture a sufficient number of seizures.
Reevaluation of whether continued EMU monitoring will capture a spell is typically done after 3, 5, and 7 days, although admissions may be longer or shorter than that. Admissions may need to be longer than 7 days to capture sufficient seizures for presurgical evaluation. Some individuals have seizures in the EMU less frequently than anticipated, and it is medically indicated to continue monitoring to capture more seizures to localize their onset. If seizures happen even as frequently as every other day, then the admission would need to be 10 days to capture 5 events. A subset of people will need a repeat VEEG study to answer the clinical question. 44 Individuals with intracranial electrodes often require 14-21 days of monitoring to capture sufficient seizures to localize the onset and perform cortical mapping. Conversely, in other circumstances, as is often the case for nonepileptic events, spells are captured early in the admission, and so individuals may be discharged after only 1 or 2 days. Thus, the length of stay in an EMU is highly variable and there is no standard recommendation, but due to the risks associated with inducing seizures, admitting a patient for observation is not recommended. Once a sufficient number of events are captured on VEEG, the interdisciplinary team of the epilepsy center is able to do a full clinical assessment and develop a treatment plan for the patient or make the appropriate referral for other medical or surgical services. 13 and clustering. 13, 45, [53] [54] [55] Although widely used, AED withdrawal is not risk-free, and should only be undertaken in the EMU setting that can ensure a "culture of safety" where staff expertise, training, and safety protocols minimize or mitigate the risks to the individual. 50, 56, 57 Strict practices commensurate with "culture of safety" should be followed 14, 56, 58 and even enhanced during the periods of higher vulnerability for seizures while medications are being reduced or stopped. This implies that the staff, logistics, and protocols for handling all possible ensuing medical emergencies, including cardiac or respiratory arrest, should be in place. 14, 56, 58 An expert consensus panel evaluating EMU safety recommended: "(i) Plans to withdraw antiseizure drugs should be individualized to consider patient-and drug-specific factors in relation to need to capture events; (ii) When tapering or stopping antiseizure drugs that affect mood, pain or other comorbid conditions, patients should be educated about potential changes and need for observation; (iii) The use and type of seizure provocation during EEG telemetry should be considered carefully in patients with history of seizure clusters or status epilepticus; (iv) If restarting antiseizure drugs, establish therapeutic doses as quickly as possible with attention to drug pharmacokinetics, drug interactions, side effects, and tolerance." However, a consensus was not reached regarding AED dose reduction, although experts indicated that "discontinuation prior to admission" . . . "should be considered only in exceptional circumstances." 14 
| Sleep deprivation
Most EMUs incorporate some amount of sleep deprivation as a seizure-provoking procedure. In a large (N = 1667) international (U.S.A., Denmark, and Norway) survey of twins and their relatives with epilepsy, 59 sleep deprivation was reported as the second most frequent of 37 offered seizure precipitants, recognized by 11.6% of all participants. Others claim that sleep deprivation is reported as a seizure precipitant by up to one-third of patients with epilepsy. 60 Sleep deprivation certainly may trigger idiopathic generalized epilepsies. 61 Although 1 study found that sleep deprivation did not affect seizure frequency in the EMU, some EMUs incorporate sleep deprivation as one of the seizure provoking procedures. 
| Exercise
Exhaustion, fatigue, or physical activities are frequently reported seizure triggers. 63 An in-bed foot cycle or a stationary bicycle at the bedside is part of the exercise equipment for some EMUs. It is a prudent strategy to have an appropriate form of physical activity included in an individualized plan for optimizing patient satisfaction and provoking seizures. 14, 56 For a small group of individuals, their seizures are specifically exercise-induced and a regimen of physical activity in the EMU is required. 64 Having a patient exercise may be a useful trigger for seizures but must be balanced against the risks of falls and related injuries.
| Other precipitants
Photic stimulation and hyperventilation are standard practice during routine outpatient EEGs. [65] [66] [67] [68] [69] Some EMUs incorporate them on a regular basis, but this is uncommon, despite several studies suggesting that hyperventilation increases yield of eliciting some types of seizures. 65, 70, 71 Alcohol may precipitate seizures in some individuals, 72, 73 but its use in an inpatient setting is problematic. Food restriction has been considered but is also uncommon. The logical precipitant 
| INTRACRANIAL VEEG MONITORING AND CORTICAL MAPPING IN THE EMU
Epilepsy surgery evaluation is directed at confidently identifying the seizure focus and ensuring that resection of the focus will not lead to neurological problems. Intracranial electrode placement and monitoring are indicated when the seizure focus cannot be localized by noninvasive methods. A plan for intracranial electrode placement is typically designed by the epileptologist and neurosurgeon at a multidisciplinary epilepsy surgery conference. Intracranial electrodes, which consist of metal electrodes embedded in inert plastic, are placed in the operating room under general anesthesia. Linear strips of 4-10 electrode contacts are inserted into the subdural space through burr holes, while grids containing up to 64 electrodes in an 8 by 8 array are placed onto the subdural surface of the brain through a craniotomy. Depth electrodes or stereo-EEG electrodes are inserted via small burr holes and stereotactically guided to a specific deep location. After electrode implantation surgery, the individual is moved to the EMU for VEEG monitoring once he or she is medically stable. The EEG is monitored through the externalized electrode "tails," the cable connecting the electrode to the recording amplifier. Seizures are recorded following similar protocols to those used in individuals with scalp EEG monitoring, but with additional safety measures, because potentially violent movements produced by seizures pose additional risks to individuals with implanted electrodes. Specialized nursing and EEG technologist care are required at the time of seizures to ensure electrodes are not dislodged, to reapply head bandages to avoid infection, and to monitor for CSF leakage and bleeding. Some centers also utilize extra precautions to minimize the risk of falls, such as the use of bedside commodes, lap belts, or a safety harness attached to a rail system on the ceiling.
Hospitalization for intracranial monitoring (phase II study) is usually longer than for scalp VEEG monitoring (phase I study). The longest stays for phase II monitoring may be 30 days or longer, but admissions are typically limited to minimize risk of infection. Some centers will observe the patient in an ICU or intermediate care unit for the first 24 hours after intracranial electrode implantation before transferring to the EMU. After recovery following intracranial electrode placement, drug tapering may begin at a rate determined by the treating physicians to reduce the time spent with intracranial electrodes. More seizures may need to be captured to localize the seizure focus during intracranial monitoring than during routine scalp monitoring, because the focus location must be precisely localized before resection. Also, the interpretation of intracranial EEG is complicated, so it usually requires capturing more seizures to accurately identify the site of onset and exclude the possibility of >1 focus.
Intracranial electrodes are also used for electrical cortical stimulation to map language areas, motor cortex, and other eloquent cortex or to record somatosensory evoked potentials, which can take many hours. Cortical stimulation may also be used to trigger seizures during stereoencephalography. 83 In the past, this mapping was done in the operating room; however, to avoid the consciousnessclouding effects of anesthesia and the time constraints of the operating room, mapping procedures are now typically performed in a more deliberate, less rushed fashion in the EMU. Cortical mapping requires a high level of participation by the individual being tested, so it cannot be done during the postictal period of lethargy or confusion after a seizure. For someone with frequent seizures, it may take days to get a window of opportunity during which this can be performed. Thus, whereas scalp VEEG monitoring can usually be accomplished in a matter of days, intracranial monitoring may take as long as several weeks.
| CONCLUSION
VEEG monitoring is a tool to optimize the treatment of individuals with paroxysmal events of many types. VEEG is increasingly being utilized in the management of critically ill patients in the ICU or on medical or surgical wards, but the indications and methodology for studies in these settings are different than for studies in the EMU. 84, 85 The VEEG recording technology, but not the testing and safety protocols of the EMU, can be deployed in the outpatient setting with ambulatory recordings. However, strategies that increase the likelihood of seizures are dangerous to individuals and cannot be performed outside of a true EMU. The risks associated with inducing seizures should preclude consideration of "observation status" as opposed to formal admission. As mentioned above, the utility of this VEEG evaluation in the EMU can lead to early and correct diagnosis in a variety of clinical circumstances. Well-trained interdisciplinary teams of providers are needed to adequately address the clinical questions summarized here, making an NAEC-certified center with an EMU an invaluable resource for patients and their providers.
